NCT00286793 2011-06-29Safety and Efficacy Study of AT-101 in Combination With Docetaxel and Prednisone in Men With HRPCAscenta TherapeuticsPhase 1/2 Completed76 enrolled
NCT00286806 2010-08-24A Study of Single-Agent AT-101 in Men With Hormone Refractory Prostate CancerAscenta TherapeuticsPhase 1/2 Completed27 enrolled
NCT00397293 2010-08-24Study of AT-101 in Combination With Topotecan in Relapsed/Refractory Small Cell Lung CancerAscenta TherapeuticsPhase 1/2 Completed36 enrolled